According to Aroa Biosurgery latest financial reports the cash on hand of ARX is $28.62M, an decrease of -19.41% to 2022. At the end of 2022 company had $35.51M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $28.62M | -19.41% |
2022 | $35.51M | 57.23% |
2021 | $22.59M | -20.01% |
2020 | $28.24M | - |